Market Overview

UPDATE: Separately, Perrigo Reports Suspension Of Sales Of Guaifenesin 600mg Extended Relaes Pending Resolution Of Challenges Related To Excipient Used In Production Of Product, Expected To Have Minimal Impact On Q4 EPS

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News Guidance Contracts

 

Related Articles (PRGO)